FOR US AUDIENCES ONLY

Contact

About lwolfe63

This author has not yet filled in any details.
So far lwolfe63 has created 6 blog entries.

ExEm® Foam, the only FDA-approved contrast agent for ultrasound tubal patency testing, now available in the U.S.

2021-09-02T16:34:12+00:00

NASHVILLE, TN –(BUSINESS WIRE)– New diagnostic is less invasive and more convenient compared to standard of care ExEm® Foam Inc announced today that ExEm® Foam ((air polymer-type A) intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics nationwide. The Foam procedure, a new ultrasound technique of hysterosalpingo foam sonography (HyFoSy), uses ExEm® Foam to assess whether there may be a blockage in the fallopian tubes in women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine. "For couples experiencing infertility, we must evaluate a number of different aspects of the reproductive system to determine the root cause. Unfortunately, this evaluation can involve a lengthy process and several uncomfortable procedures," said Professor Mark Hans Emanuel, M.D., Ph.D., Department Gynecology and Reproductive Medicine, University Medical Center Utrecht, The Netherlands, and co-inventor of the Foam procedure. "Cutting-edge, safe and effective diagnostic procedures, like the Foam procedure, allow us to quickly and as comfortably as possible identify fertility issues and plan the next step in a patient’s fertility journey.” Blockage of the fallopian tubes accounts for infertility in approximately 20% of couples who are having difficulty conceiving.[1] HSG using iodine and X-ray, laparoscopy or saline/air hysterosalpingo contrast sonography (HyCoSy) are commonly used to determine tubal patency but have several limitations. For example, X-Ray HSG is generally a more painful and time-consuming procedure, and HyCoSy uses an unapproved air-saline mixture that can produce lower image quality and accuracy. "With a growing demand for assisted reproductive technologies and a downward trend for using radiation in women trying to conceive, there is a huge need for a gentler and more patient-friendly tubal patency test," said Johan Remmerswaal, President, ExEm Foam Inc. “We are proud to be able to fulfill this need with the Foam procedure by quickly, safely and accurately assessing the patency of the fallopian tubes in the comfort of a patient’s gynecologist office.” ExEm Foam, approved by the U.S. Food and Drug Administration in 2019, has been used in more than 500,000 tubal patency procedures worldwide since it first launched in Europe in 2011. For more information, please visit www.ExEmFoam.com.‍‍ About ExEm® Foam (air polymer-type A) intrauterine foamExEm® Foam ((air polymer-type A) intrauterine foam) is an innovative, FDA-approved product that offers a less invasive ultrasound procedure, a highly accurate alternative to other tubal patency assessment procedures, like laparoscopy or X-ray HSG. The contrast agent allows for easy recognition of tubal patency using the Foam procedure. During the tubal patency procedure, the foam is infused into the uterus by a healthcare professional to allow for visual assessment of fallopian tubes. If the tubes are patent the foam will appear as a thin, bright white line [...]

ExEm® Foam, the only FDA-approved contrast agent for ultrasound tubal patency testing, now available in the U.S.2021-09-02T16:34:12+00:00

NYU Langone Health

2021-09-01T22:38:51+00:00

NYU Langone Health The ExEm® Foam Inc. team was excited to meet with the renowned Dr. Steven R. Goldstein, M.D. this past week at NYU Langone Health, one of the nation’s premier academic medical centers located in the heart of Manhattan. The goal of the visit was to introduce a new technology in tubal patency testing for women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine. ExEm® Foam Inc. continues to visit and train healthcare professionals in facilities across the US. Contact us for more information if you are interested in using ExEm® Foam ((air polymer-type A) intrauterine foam) for your patients.

NYU Langone Health2021-09-01T22:38:51+00:00

Johns Hopkins Medicine

2021-09-02T00:07:06+00:00

Johns Hopkins Medicine The first president of Johns Hopkins University, Daniel Coit Gilman, believed that teaching and research go hand in hand. He presumed that success in one depends on success in the other. He also believed that sharing knowledge and discoveries would help make the world a better place. That's why our team was very pleased to visit Johns Hopkins Medicine to introduce the clinic to our new technology in tubal patency testing for women with known or suspected infertility. This Foam procedure offers a less complicated, less invasive alternative to the gold standard for diagnosing tubal patency - laparoscopy.1 We are working tirelessly to visit and train new US facilities, virtually and, where possible, in-person. Don't hesitate to reach out for more information about ExEm® Foam ((air polymer-type A) intrauterine foam) and follow us on LinkedIn for the latest updates.

Johns Hopkins Medicine2021-09-02T00:07:06+00:00

Texas Children’s Hospital

2021-09-02T00:11:18+00:00

Texas Children's Hospital The ExEm® Foam Inc team visited Texas Children's Hospital to introduce them to the Foam procedure. The hospital prides itself for providing the most advanced fertility treatments to help patients conceive. With ExEm® Foam ((air polymer-type A) intrauterine foam), women with known or suspected infertility can have a tubal patency test from the comfort of their gynecologist's office, allowing real-time results. We continue the launch of the Foam procedure in clinics throughout the US. Don't hesitate to contact us for more information and follow us on LinkedIn for the latest updates.

Texas Children’s Hospital2021-09-02T00:11:18+00:00

ExEm Foam Team visits Mayo Clinic Rochester

2021-09-02T00:10:06+00:00

ExEm Foam Team visits Mayo Clinic Rochester The ExEm® Foam Team was excited to visit the Mayo Clinic Rochester to officially bring the Foam Procedure to the US.The new technology in tubal patency testing in women with know or suspected infertility, offers fertility clinics an alternative to the 50+ year old X-ray HSG technology. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine. This means that physicians can now expect a clear imaging quality using their own ultrasound machine and that patients can have a more gentle procedure by their trusted fertility expert.

ExEm Foam Team visits Mayo Clinic Rochester2021-09-02T00:10:06+00:00

ASRM 2019 Scientific Congress Prize Paper Session 1

2021-09-01T22:20:45+00:00

ASRM 2019 Scientific Congress Prize Paper Session 1 The first six papers are candidates for the ASRM Scientific Congress Prize Paper Awards. Six additional candidates will be presented during the Prize Paper Candidates’ session on Tuesday.

ASRM 2019 Scientific Congress Prize Paper Session 12021-09-01T22:20:45+00:00
Go to Top